• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IFN-λ-IFN-λR1-IL-10Rβ复合物揭示了III型干扰素功能可塑性的结构特征。

The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity.

作者信息

Mendoza Juan L, Schneider William M, Hoffmann Hans-Heinrich, Vercauteren Koen, Jude Kevin M, Xiong Anming, Moraga Ignacio, Horton Tim M, Glenn Jeffrey S, de Jong Ype P, Rice Charles M, Garcia K Christopher

机构信息

Howard Hughes Medical Institute, Department of Molecular and Cellular Physiology and Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

出版信息

Immunity. 2017 Mar 21;46(3):379-392. doi: 10.1016/j.immuni.2017.02.017.

DOI:10.1016/j.immuni.2017.02.017
PMID:28329704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5510750/
Abstract

Type III interferons (IFN-λs) signal through a heterodimeric receptor complex composed of the IFN-λR1 subunit, specific for IFN-λs, and interleukin-10Rβ (IL-10Rβ), which is shared by multiple cytokines in the IL-10 superfamily. Low affinity of IL-10Rβ for cytokines has impeded efforts aimed at crystallizing cytokine-receptor complexes. We used yeast surface display to engineer a higher-affinity IFN-λ variant, H11, which enabled crystallization of the ternary complex. The structure revealed that IL-10Rβ uses a network of tyrosine residues as hydrophobic anchor points to engage IL-10 family cytokines that present complementary hydrophobic binding patches, explaining its role as both a cross-reactive but cytokine-specific receptor. H11 elicited increased anti-proliferative and antiviral activities in vitro and in vivo. In contrast, engineered higher-affinity type I IFNs did not increase antiviral potency over wild-type type I IFNs. Our findings provide insight into cytokine recognition by the IL-10R family and highlight the plasticity of type III interferon signaling and its therapeutic potential.

摘要

III型干扰素(IFN-λs)通过一种异二聚体受体复合物进行信号传导,该复合物由对IFN-λs具有特异性的IFN-λR1亚基和白细胞介素10受体β(IL-10Rβ)组成,IL-10Rβ为IL-10超家族中的多种细胞因子所共有。IL-10Rβ对细胞因子的低亲和力阻碍了细胞因子-受体复合物结晶的相关研究。我们利用酵母表面展示技术构建了一种高亲和力的IFN-λ变体H11,它能够使三元复合物结晶。该结构表明,IL-10Rβ利用酪氨酸残基网络作为疏水锚定点,与呈现互补疏水结合位点的IL-10家族细胞因子结合,这解释了其作为交叉反应但细胞因子特异性受体的作用。H11在体外和体内均引发了增强的抗增殖和抗病毒活性。相比之下,构建的高亲和力I型干扰素在抗病毒效力上并未超过野生型I型干扰素。我们的研究结果为IL-10R家族对细胞因子的识别提供了见解,并突出了III型干扰素信号传导的可塑性及其治疗潜力。

相似文献

1
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity.IFN-λ-IFN-λR1-IL-10Rβ复合物揭示了III型干扰素功能可塑性的结构特征。
Immunity. 2017 Mar 21;46(3):379-392. doi: 10.1016/j.immuni.2017.02.017.
2
Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.酪氨酸激酶 2 并不限制人体抗病毒的 III 型干扰素反应。
Eur J Immunol. 2016 Nov;46(11):2639-2649. doi: 10.1002/eji.201646519. Epub 2016 Oct 5.
3
Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1.鉴定用于检测人干扰素-λ受体 1 细胞表面蛋白水平的单克隆抗体
J Interferon Cytokine Res. 2023 Sep;43(9):403-413. doi: 10.1089/jir.2023.0040. Epub 2023 Jul 27.
4
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.干扰素-λ受体 1 剪接变异体的差异表达决定了干扰素-λ 3 在人免疫细胞中诱导的抗病毒反应的幅度。
PLoS Pathog. 2020 Apr 30;16(4):e1008515. doi: 10.1371/journal.ppat.1008515. eCollection 2020 Apr.
5
Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1.人干扰素-λ1 与其高亲和力受体干扰素-λR1 复合物的晶体结构。
J Mol Biol. 2010 Dec 10;404(4):650-64. doi: 10.1016/j.jmb.2010.09.068. Epub 2010 Oct 8.
6
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.小鼠干扰素-λ配体-受体系统的特性:干扰素-λ对B16黑色素瘤具有抗肿瘤活性。
Cancer Res. 2006 Apr 15;66(8):4468-77. doi: 10.1158/0008-5472.CAN-05-3653.
7
Novel type III interferons produce anti-tumor effects through multiple functions.新型 III 型干扰素通过多种功能产生抗肿瘤作用。
Front Biosci (Landmark Ed). 2013 Jun 1;18(3):909-18. doi: 10.2741/4152.
8
Antiviral activity of bovine type III interferon against bovine viral diarrhea virus is greatly reduced in bovine turbinate cells due to limited expression of IFN lambda receptor 1 (IL-28Rα).牛鼻甲骨细胞中干扰素 lambda 受体 1(IL-28Rα)表达有限,导致牛 III 型干扰素对牛病毒性腹泻病毒的抗病毒活性大大降低。
Front Immunol. 2024 Aug 19;15:1441908. doi: 10.3389/fimmu.2024.1441908. eCollection 2024.
9
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines.尽管存在 IFN-λ 受体表达,但血液免疫细胞(而非角质形成细胞或黑素细胞)对 III 型干扰素的反应受损:这对这些细胞因子的治疗应用有影响。
Genes Immun. 2009 Dec;10(8):702-14. doi: 10.1038/gene.2009.72. Epub 2009 Oct 1.
10
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.白细胞介素(IL)-28受体酪氨酸残基在IL-29/干扰素-λ1的抗病毒和抗增殖活性中的作用:与I型干扰素信号传导的相似性
J Biol Chem. 2004 Jul 30;279(31):32269-74. doi: 10.1074/jbc.M404789200. Epub 2004 May 27.

引用本文的文献

1
Updates on Recent Advancements in Hepatitis D Virus Treatment.丁型肝炎病毒治疗的最新进展
Viruses. 2025 Aug 10;17(8):1100. doi: 10.3390/v17081100.
2
Expanding the cytokine receptor alphabet reprograms T cells into diverse states.扩展细胞因子受体种类可将T细胞重编程为多种不同状态。
Nature. 2025 Aug 13. doi: 10.1038/s41586-025-09393-1.
3
Transcriptional regulation and signaling of type IV interferon in Carassius gibelio.异育银鲫IV型干扰素的转录调控与信号传导

本文引用的文献

1
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.高效植入胎儿肝母细胞和同基因免疫细胞的人源化小鼠可发育出人类单核细胞和自然杀伤细胞。
J Hepatol. 2016 Aug;65(2):334-43. doi: 10.1016/j.jhep.2016.04.022. Epub 2016 May 2.
2
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).佩格干扰素 lambda 治疗 HBeAg 阳性慢性乙型肝炎:一项随机 2b 期研究(LIRA-B)。
J Hepatol. 2016 May;64(5):1011-1019. doi: 10.1016/j.jhep.2015.12.018. Epub 2015 Dec 29.
3
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.
Cell Commun Signal. 2025 Jul 11;23(1):335. doi: 10.1186/s12964-025-02342-5.
4
Role of Innate Immunity in Cancer.先天免疫在癌症中的作用。
Adv Exp Med Biol. 2025;1476:309-337. doi: 10.1007/978-3-031-85340-1_13.
5
Interferon Lambda: The Next Frontier in Antiviral Therapy?干扰素λ:抗病毒治疗的新前沿?
Pharmaceuticals (Basel). 2025 May 24;18(6):785. doi: 10.3390/ph18060785.
6
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.低强度I型干扰素信号传导促进CAR T细胞治疗疗效。
bioRxiv. 2025 May 20:2025.05.13.653878. doi: 10.1101/2025.05.13.653878.
7
Soluble Herpes Virus Entry Mediator and Type II/III Interferons Are Upregulated in Primary Biliary Cholangitis.可溶性疱疹病毒进入介质及II型/III型干扰素在原发性胆汁性胆管炎中上调。
Int J Mol Sci. 2025 Jan 13;26(2):605. doi: 10.3390/ijms26020605.
8
Structural studies of the IFNλ4 receptor complex using cryoEM enabled by protein engineering.利用蛋白质工程通过冷冻电镜对IFNλ4受体复合物进行结构研究。
Nat Commun. 2025 Jan 18;16(1):818. doi: 10.1038/s41467-025-56119-y.
9
Engineered chimeric receptors for dissecting interferon signaling.用于解析干扰素信号的工程化嵌合受体。
J Virol. 2024 Oct 22;98(10):e0168023. doi: 10.1128/jvi.01680-23. Epub 2024 Sep 18.
10
In search of a function for human type III interferons: insights from inherited and acquired deficits.探索人类 III 型干扰素的功能:遗传性和获得性缺陷的启示。
Curr Opin Immunol. 2024 Apr;87:102427. doi: 10.1016/j.coi.2024.102427. Epub 2024 May 22.
干扰素-λ:屏障表面及其他部位的免疫功能
Immunity. 2015 Jul 21;43(1):15-28. doi: 10.1016/j.immuni.2015.07.001.
4
Insights into cytokine-receptor interactions from cytokine engineering.细胞因子工程对细胞因子-受体相互作用的见解。
Annu Rev Immunol. 2015;33:139-67. doi: 10.1146/annurev-immunol-032713-120211. Epub 2014 Dec 10.
5
Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.共生微生物和干扰素-λ决定肠道小鼠诺如病毒感染的持续性。
Science. 2015 Jan 16;347(6219):266-9. doi: 10.1126/science.1258025. Epub 2014 Nov 27.
6
Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.在缺乏适应性免疫的情况下,干扰素λ可治愈持续性小鼠诺如病毒感染。
Science. 2015 Jan 16;347(6219):269-73. doi: 10.1126/science.1258100. Epub 2014 Nov 27.
7
Broadly neutralizing antibodies abrogate established hepatitis C virus infection.广泛中和抗体可消除已有的丙型肝炎病毒感染。
Sci Transl Med. 2014 Sep 17;6(254):254ra129. doi: 10.1126/scitranslmed.3009512.
8
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.使用原代和诱导多能干细胞衍生的肝细胞系统对乙型肝炎病毒与宿主相互作用进行建模。
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12193-8. doi: 10.1073/pnas.1412631111. Epub 2014 Aug 4.
9
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.一项聚乙二醇干扰素 lambda-1a 治疗慢性 HCV 感染的随机 2b 期研究。
J Hepatol. 2014 Dec;61(6):1238-46. doi: 10.1016/j.jhep.2014.07.022. Epub 2014 Jul 24.
10
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates.聚乙二醇干扰素λ-1a用于慢性丙型肝炎的3期给药方案推导,第1部分:最佳治疗持续时间和持续病毒学应答率建模
J Clin Pharmacol. 2015 Jan;55(1):63-72. doi: 10.1002/jcph.363. Epub 2014 Jul 24.